Conference Coverage

ASCO: Omitting adjuvant radiation after pCR ups locoregional recurrence risk

Publish date: June 9, 2015

 

AT THE 2015 ASCO ANNUAL MEETING

References

Multivariate analysis here again showed that radiation therapy independently predicted better locoregional recurrence–free survival (HR, 0.56; P = .029) but not disease-free survival.

Pages

Recommended Reading

Ultrasound after neoadjuvant chemo can guide axillary surgery decisions
MDedge Surgery
Cancer mortality lowest in western United States
MDedge Surgery
More cancer patients surviving longer, but age-based disparities remain
MDedge Surgery
Indocyanine green technique detects sentinel nodes in breast cancers
MDedge Surgery
Physician-patient communication, terminology play important role in CPM decisions
MDedge Surgery
Neoadjuvant therapy facilitates breast conservation
MDedge Surgery
Oophorectomy improves survival after breast cancer in BRCA1 carriers
MDedge Surgery
ASA: Radiation lowers local recurrence risk for DCIS patients with close or positive margins
MDedge Surgery
Neoadjuvant chemotherapy for triple negative breast cancer improves conservation
MDedge Surgery
ASCO: Precision medicine initiatives take wing
MDedge Surgery